The Lower Insulin Costs Now Act will help make cheaper generic insulin available more quickly.
Underwood’s bipartisan Lower Insulin Costs Now Act will reduce the cost of insulin by helping lower-cost, generic insulin become available sooner. The Lower Insulin Costs Now Act will allow the FDA to continue to review applications for generic insulin beyond the looming March 2020 cut-off date, creating access to new treatments that can lower the cost of insulin for those who rely on it to survive. Over 1 million Illinoisans are living with type I or type II diabetes, including one in four seniors and a growing number of children in America. Along with Underwood, the legislation was led by Representatives Jan Schakowsky (IL-09), Brett Guthrie (KY-02), and Mike Kelly (PA-16).
"Over the past two decades, the cost of insulin has skyrocketed—it’s unaffordable. I've heard from countless families in our community about the hard decisions they make to afford their insulin, including rationing their supply or going without. This is unacceptable—over 7 million Americans rely on insulin to survive," Rep. Underwood said. "There isn’t a person I won’t work with to lower the cost of prescription drugs, and I’m thrilled my colleagues in Congress and the President supported this advancement toward making lower-cost, generic insulin available more quickly."